-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News on May 27th.
Long-acting Shengbaiyao has just been approved.
Recently, Shandong New Times Pharmaceuticals has approved three more varieties, including axitinib tablets, lipoic acid injection, and tenofovir fumarate.
Dipyrifurate tablets.
Among them, axitinib tablet is the first domestic imitation + first review, and lipoic acid injection is the fifth batch of collected varieties.
Long-acting Shengbaiyao has just been approved.
Recently, Shandong New Times Pharmaceuticals has approved three more varieties, including axitinib tablets, lipoic acid injection, and tenofovir fumarate.
Dipyrifurate tablets.
Among them, axitinib tablet is the first domestic imitation + first review, and lipoic acid injection is the fifth batch of collected varieties.
New Era Pharmaceuticals has recently been approved for listing
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Axitinib tablets (Inlyta) is a new generation of renal cancer targeted therapy developed by Pfizer.
It is mainly used for adult patients with advanced renal cancer who have failed previous cytokine-related treatment regimens.
It is one of the standard treatment options for advanced renal cancer.
.
Shandong New Era's axitinib tablet is the first domestic imitation + first review.
It is mainly used for adult patients with advanced renal cancer who have failed previous cytokine-related treatment regimens.
It is one of the standard treatment options for advanced renal cancer.
.
Shandong New Era's axitinib tablet is the first domestic imitation + first review.
According to data from Meinenet, Inlyta’s global sales in 2020 will be 787 million U.
S.
dollars, and its terminal sales in China’s urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will be close to 300 million yuan, year-on-year An increase of 170.
16%.
S.
dollars, and its terminal sales in China’s urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will be close to 300 million yuan, year-on-year An increase of 170.
16%.
Global sales of Inlyta (unit: million dollars)
Source: Mynet.
com's sales database of multinational listed companies
com's sales database of multinational listed companies
Lipoic acid injection medication for diabetes, for paresthesia and other oxidative stress-induced diabetic peripheral neuropathy caused by disease .
The original research drug of this product is Austrian Stadt, Germany.
It has been used for the treatment of diabetic neuropathy in Germany for decades, and some domestic manufacturers also use it as a liver protectant.
The original research drug of this product is Austrian Stadt, Germany.
It has been used for the treatment of diabetic neuropathy in Germany for decades, and some domestic manufacturers also use it as a liver protectant.
Lipoic Acid Injection Over-rated Enterprise
Source: One-click search on Mi Nei.
com
com
Lipoic acid injection is the fifth batch of centralized procurement varieties, and Shandong New Era rushed to obtain admission tickets before the bid opening.
According to data from Meinenet, the sales of terminal lipoic acid injections in China's public medical institutions will exceed 1 billion yuan in 2020.
At present, there are 20 lipoic acid injection manufacturers in the domestic market, but only 4 companies have been reviewed, including Yabao Pharmaceutical, Chengdu Better Pharmaceutical, Sichuan Meidakang Huakang Pharmaceutical, and Shandong New Times Pharmaceutical.
According to data from Meinenet, the sales of terminal lipoic acid injections in China's public medical institutions will exceed 1 billion yuan in 2020.
At present, there are 20 lipoic acid injection manufacturers in the domestic market, but only 4 companies have been reviewed, including Yabao Pharmaceutical, Chengdu Better Pharmaceutical, Sichuan Meidakang Huakang Pharmaceutical, and Shandong New Times Pharmaceutical.
Tenofovir disoproxil fumarate tablets are oral nucleoside antiviral drugs developed by Gilead.
It has the advantages of stronger antiviral efficacy, zero drug resistance, and pregnancy grade B.
It has been prevented and treated by chronic hepatitis B in various countries.
The guidelines unanimously recommend first-line drugs for the treatment of chronic hepatitis B infection and human immunodeficiency virus type 1 (HIV-1) infection in adults and children 12 years and older .
Tenofovir disoproxil fumarate tablets have been included in the first batch of centralized procurement, and currently as many as 22 companies have reviewed it.
It has the advantages of stronger antiviral efficacy, zero drug resistance, and pregnancy grade B.
It has been prevented and treated by chronic hepatitis B in various countries.
The guidelines unanimously recommend first-line drugs for the treatment of chronic hepatitis B infection and human immunodeficiency virus type 1 (HIV-1) infection in adults and children 12 years and older .
Tenofovir disoproxil fumarate tablets have been included in the first batch of centralized procurement, and currently as many as 22 companies have reviewed it.
Data source: Mi Neiwang database
Medical Network News on May 27th.
Long-acting Shengbaiyao has just been approved.
Recently, Shandong New Times Pharmaceuticals has approved three more varieties, including axitinib tablets, lipoic acid injection, and tenofovir fumarate.
Dipyrifurate tablets.
Among them, axitinib tablet is the first domestic imitation + first review, and lipoic acid injection is the fifth batch of collected varieties.
Long-acting Shengbaiyao has just been approved.
Recently, Shandong New Times Pharmaceuticals has approved three more varieties, including axitinib tablets, lipoic acid injection, and tenofovir fumarate.
Dipyrifurate tablets.
Among them, axitinib tablet is the first domestic imitation + first review, and lipoic acid injection is the fifth batch of collected varieties.
New Era Pharmaceuticals has recently been approved for listing
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Axitinib tablets (Inlyta) is a new generation of renal cancer targeted therapy developed by Pfizer.
It is mainly used for adult patients with advanced renal cancer who have failed previous cytokine-related treatment regimens.
It is one of the standard treatment options for advanced renal cancer.
.
Shandong New Era's axitinib tablet is the first domestic imitation + first review.
It is mainly used for adult patients with advanced renal cancer who have failed previous cytokine-related treatment regimens.
It is one of the standard treatment options for advanced renal cancer.
.
Shandong New Era's axitinib tablet is the first domestic imitation + first review.
According to data from Meinenet, Inlyta’s global sales in 2020 will be 787 million U.
S.
dollars, and its terminal sales in China’s urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will be close to 300 million yuan, year-on-year An increase of 170.
16%.
S.
dollars, and its terminal sales in China’s urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will be close to 300 million yuan, year-on-year An increase of 170.
16%.
Global sales of Inlyta (unit: million dollars)
Source: Mynet.
com's sales database of multinational listed companies
com's sales database of multinational listed companies
Lipoic acid injection medication for diabetes, for paresthesia and other oxidative stress-induced diabetic peripheral neuropathy caused by disease .
The original research drug of this product is Austrian Stadt, Germany.
It has been used for the treatment of diabetic neuropathy in Germany for decades, and some domestic manufacturers also use it as a liver protectant.
The original research drug of this product is Austrian Stadt, Germany.
It has been used for the treatment of diabetic neuropathy in Germany for decades, and some domestic manufacturers also use it as a liver protectant.
Lipoic Acid Injection Over-rated Enterprise
Source: One-click search on Mi Nei.
com
com
Lipoic acid injection is the fifth batch of centralized procurement varieties, and Shandong New Era rushed to obtain admission tickets before the bid opening.
According to data from Meinenet, the sales of terminal lipoic acid injections in China's public medical institutions will exceed 1 billion yuan in 2020.
At present, there are 20 lipoic acid injection manufacturers in the domestic market, but only 4 companies have been reviewed, including Yabao Pharmaceutical, Chengdu Better Pharmaceutical, Sichuan Meidakang Huakang Pharmaceutical, and Shandong New Times Pharmaceutical.
According to data from Meinenet, the sales of terminal lipoic acid injections in China's public medical institutions will exceed 1 billion yuan in 2020.
At present, there are 20 lipoic acid injection manufacturers in the domestic market, but only 4 companies have been reviewed, including Yabao Pharmaceutical, Chengdu Better Pharmaceutical, Sichuan Meidakang Huakang Pharmaceutical, and Shandong New Times Pharmaceutical.
Tenofovir disoproxil fumarate tablets are oral nucleoside antiviral drugs developed by Gilead.
It has the advantages of stronger antiviral efficacy, zero drug resistance, and pregnancy grade B.
It has been prevented and treated by chronic hepatitis B in various countries.
The guidelines unanimously recommend first-line drugs for the treatment of chronic hepatitis B infection and human immunodeficiency virus type 1 (HIV-1) infection in adults and children 12 years and older .
Tenofovir disoproxil fumarate tablets have been included in the first batch of centralized procurement, and currently as many as 22 companies have reviewed it.
It has the advantages of stronger antiviral efficacy, zero drug resistance, and pregnancy grade B.
It has been prevented and treated by chronic hepatitis B in various countries.
The guidelines unanimously recommend first-line drugs for the treatment of chronic hepatitis B infection and human immunodeficiency virus type 1 (HIV-1) infection in adults and children 12 years and older .
Tenofovir disoproxil fumarate tablets have been included in the first batch of centralized procurement, and currently as many as 22 companies have reviewed it.
Data source: Mi Neiwang database
Medical Network News on May 27th.
Long-acting Shengbaiyao has just been approved.
Recently, Shandong New Times Pharmaceuticals has approved three more varieties, including axitinib tablets, lipoic acid injection, and tenofovir fumarate.
Dipyrifurate tablets.
Among them, axitinib tablet is the first domestic imitation + first review, and lipoic acid injection is the fifth batch of collected varieties.
Long-acting Shengbaiyao has just been approved.
Recently, Shandong New Times Pharmaceuticals has approved three more varieties, including axitinib tablets, lipoic acid injection, and tenofovir fumarate.
Dipyrifurate tablets.
Among them, axitinib tablet is the first domestic imitation + first review, and lipoic acid injection is the fifth batch of collected varieties.
New Era Pharmaceuticals has recently been approved for listing
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Axitinib tablets (Inlyta) is a new generation of renal cancer targeted therapy developed by Pfizer.
It is mainly used for adult patients with advanced renal cancer who have failed previous cytokine-related treatment regimens.
It is one of the standard treatment options for advanced renal cancer.
.
Shandong New Era's axitinib tablet is the first domestic imitation + first review.
Standard Standard StandardIt is mainly used for adult patients with advanced renal cancer who have failed previous cytokine-related treatment regimens.
It is one of the standard treatment options for advanced renal cancer.
.
Shandong New Era's axitinib tablet is the first domestic imitation + first review.
According to data from Meinenet, Inlyta’s global sales in 2020 will be 787 million U.
S.
dollars, and its terminal sales in China’s urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will be close to 300 million yuan, year-on-year An increase of 170.
16%.
Hospital hospital hospitalS.
dollars, and its terminal sales in China’s urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will be close to 300 million yuan, year-on-year An increase of 170.
16%.
Global sales of Inlyta (unit: million dollars)
Source: Mynet.
com's sales database of multinational listed companies
com's sales database of multinational listed companies
Lipoic acid injection medication for diabetes, for paresthesia and other oxidative stress-induced diabetic peripheral neuropathy caused by disease .
The original research drug of this product is Austrian Stadt, Germany.
It has been used for the treatment of diabetic neuropathy in Germany for decades, and some domestic manufacturers also use it as a liver protectant.
Disease disease diseaseThe original research drug of this product is Austrian Stadt, Germany.
It has been used for the treatment of diabetic neuropathy in Germany for decades, and some domestic manufacturers also use it as a liver protectant.
Lipoic Acid Injection Over-rated Enterprise
Enterprise business enterprise Source: One-click search on Mi Nei.
com
com
Lipoic acid injection is the fifth batch of centralized procurement varieties, and Shandong New Era rushed to obtain admission tickets before the bid opening.
According to data from Meinenet, the sales of terminal lipoic acid injections in China's public medical institutions will exceed 1 billion yuan in 2020.
At present, there are 20 lipoic acid injection manufacturers in the domestic market, but only 4 companies have been reviewed, including Yabao Pharmaceutical, Chengdu Better Pharmaceutical, Sichuan Meidakang Huakang Pharmaceutical, and Shandong New Times Pharmaceutical.
According to data from Meinenet, the sales of terminal lipoic acid injections in China's public medical institutions will exceed 1 billion yuan in 2020.
At present, there are 20 lipoic acid injection manufacturers in the domestic market, but only 4 companies have been reviewed, including Yabao Pharmaceutical, Chengdu Better Pharmaceutical, Sichuan Meidakang Huakang Pharmaceutical, and Shandong New Times Pharmaceutical.
Tenofovir disoproxil fumarate tablets are oral nucleoside antiviral drugs developed by Gilead.
It has the advantages of stronger antiviral efficacy, zero drug resistance, and pregnancy grade B.
It has been prevented and treated by chronic hepatitis B in various countries.
The guidelines unanimously recommend first-line drugs for the treatment of chronic hepatitis B infection and human immunodeficiency virus type 1 (HIV-1) infection in adults and children 12 years and older .
Tenofovir disoproxil fumarate tablets have been included in the first batch of centralized procurement, and currently as many as 22 companies have reviewed it.
Child, child, kidIt has the advantages of stronger antiviral efficacy, zero drug resistance, and pregnancy grade B.
It has been prevented and treated by chronic hepatitis B in various countries.
The guidelines unanimously recommend first-line drugs for the treatment of chronic hepatitis B infection and human immunodeficiency virus type 1 (HIV-1) infection in adults and children 12 years and older .
Tenofovir disoproxil fumarate tablets have been included in the first batch of centralized procurement, and currently as many as 22 companies have reviewed it.
Data source: Mi Neiwang database
